Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05702138 · ClinicalTrials.gov registry record · Phase 2

High Intensity Step Training After Traumatic Brain Injury

A Phase 2 study of Traumatic Brain Injury, sponsored by Craig Hospital.

Recruiting
Registry status
Phase 2
Development phase
111
Enrollment target
1
Study location

NCT05702138 is a Phase 2 study of Traumatic Brain Injury that is actively recruiting participants, run by Craig Hospital. The registered enrollment target is 111 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05702138, a Phase 2 study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Craig Hospital.

RECRUITING
Registry status
Phase 2
Development phase
111 participants
Enrollment target
1
Study location

Study Summary

This study will explore whether the types and intensity of the interventions being delivered will yield measurable cognitive benefits in addition to improved mobility and balance. The study evaluates three therapeutic approaches to improve mobility and balance after traumatic brain injury (TBI): Conventional Gait and Balance Training, high intensity step training, and high intensity step training with virtual reality.

Conditions Studied

Interventions

  • OTHER Physical therapy

Study Locations (1)

Colorado

  • Craig Hospital - Englewood

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2023-03-20
Est. Completion 2027-08-31
Phase Phase 2

Sponsor

Craig Hospital

29 total trials

What the Registry Record Tells You About NCT05702138

The ClinicalTrials.gov registry entry for NCT05702138 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (60% lower). The listed sponsor is Craig Hospital, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Physical therapy is the first listed.

NCT05702138 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05702138 about?

NCT05702138 is a clinical study titled "High Intensity Step Training After Traumatic Brain Injury". This study will explore whether the types and intensity of the interventions being delivered will yield measurable cognitive benefits in addition to improved mobility and balance. The study evaluates three therapeutic approaches to improve mobility and balance after traumatic brain injury (TBI): Co...

What is the current status of trial NCT05702138?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2023-03-20. Estimated completion is 2027-08-31.

What conditions does trial NCT05702138 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT05702138?

The interventions under investigation include: Physical therapy (OTHER).

Who is sponsoring clinical trial NCT05702138?

This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05702138 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.